Oncothyreon to Present at Jefferies 2013 Global Healthcare Conference PR Newswire SEATTLE, May 29, 2013 SEATTLE, May 29, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the Jefferies 2013 Global Healthcare Conference in New York on Wednesday, June 5, 2013 at 3 p.m. Eastern. A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section. About Oncothyreon Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com. SOURCE Oncothyreon Inc. Contact: Investor and Media Relations Contact: Julie Rathbun Rathbun Communications 206-769-9219 email@example.com
Oncothyreon to Present at Jefferies 2013 Global Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.